ATXN2 and amyotrophic lateral sclerosis: No subject in the control group showed a pathological increase in CAG repeats while four subjects in the ALS group (1.7%) carried an ATXN2 gene with a pathological number of repeats (32, 33, 33, and 37 repeats), each interrupted by at least one CAA triplet [15].